HNL Lab Medicine and Ibex Medical Analytics announced a collaboration on AI-powered solutions for prostate cancer.

AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new ...

Seventy-one percent of counties that spray the most glyphosate have late-stage non-Hodgkin lymphoma incidence rates above the national average, according to a new data analysis from the advocacy group ...

In the era of data-driven medicine, biomedical imaging has evolved from a purely diagnostic tool to a cornerstone of precision healthcare. The confluence of deep learning (DL) and biomedical image ...

(Nanowerk Spotlight) In the age of big data, we are generating more images than we can actually process. Autonomous vehicles, medical scanners, and quality control systems rely heavily on ...

Scientists in South Korea have made a breakthrough in colorectal cancer research, the second-most common cause of cancer casualties in the United States. The illness refers to an abnormal growth of ...

Nearly half of cancers could be avoided by cutting out three major risk factors, a new study has revealed. Research published this week in Nature Medicine identified that nearly 40% of global cancer ...

Abstract: Image processing improve visual information to be useful in analysis in areas of medical imaging, satellite surveillance, and digital media. In this work, basic pre-processing functions, ...

Drinking heavily over many years is linked to a higher risk of colorectal cancer, especially rectal cancer, according to new research tracking U.S. adults for two decades. People who drank heavily ...

Harvey Risch, a Yale epidemiologist long respected for his work in cancer research but who has faced controversy for promoting an unproven covid-19 treatment, has been selected by President Donald ...

Automated skin lesion classification using ResNet50 transfer learning on HAM10000 dataset. Achieved ~83% accuracy across 7 diagnostic categories. MATLAB implementation for VCU Image Analysis course.

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors Accurately identifying patients who will ...